Mercedes
Salgado Fernández
![Foto de Mercedes](/img/nophoto.png)
![Foto de Universidade da Coruña](/img/noimage_org.png)
Universidade da Coruña
La Coruña, EspañaPublicacións en colaboración con investigadores/as de Universidade da Coruña (6)
2020
-
Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 351-359
-
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial
Clinical and Translational Oncology, Vol. 22, Núm. 4, pp. 495-502
-
Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
International Journal of Colorectal Disease, Vol. 35, Núm. 4, pp. 739-746
2017
-
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
European Journal of Cancer, Vol. 82, pp. 16-24
2010
-
A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer
British Journal of Cancer, Vol. 103, Núm. 10, pp. 1536-1541
-
Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy
Clinical and Translational Oncology, Vol. 12, Núm. 12, pp. 843-848